Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 5 of 5 Projects
Project # Contact PI Funding Organization Fiscal Year
Testing low-dose efavirenz treatment for Alzheimer’s disease: a phase 1b dosing, target-engagement and exploratory biomarker study.
ADDF-48 SCHELTENS, PHILIP Alzheimer's Drug Discovery Foundation 2021
A Phase IIa Trial to Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of TW001 in Alzheimer Patients
GC-2013807 van der Geest, Ronald Alzheimer's Drug Discovery Foundation 2018
Activation of microglial cells to promote clearance of amyloid-beta
GC-2013257 Parker, Michael Alzheimer's Drug Discovery Foundation 2017
New inhibitors of kynurenine-3-monooxygenase for Alzheimer's disease therapy
GC-2012229 Guillemin, Gilles Alzheimer's Drug Discovery Foundation 2015
A Randomized, Double-Blind, Placebo-Controlled Phase 2 study to evaluate the effect of PBT2 (once daily for 52 weeks) on Abeta deposition in the brain of patients with Alzheimer's Disease
20101209-Angus-2010 Angus, Dianne Alzheimer's Drug Discovery Foundation 2010